LWAM
TECH icon

Legacy Wealth Asset Management’s Bio-Techne TECH Stock Holding History

Legacy Wealth Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,959
Closed -$212K – 356
2024
Q2 		$212K Sell
2,959
-1,000
-25% -$73.6K 0.06% 323
2024
Q1 		$279K Sell
3,959
-3,407
-46% -$244K 0.08% 308
2023
Q4 		$568K Sell
7,366
-70
-0.9% -$4.61K 0.19% 187
2023
Q3 		$506K Sell
7,436
-1,500
-17% -$118K 0.19% 194
2023
Q2 		$729K Sell
8,936
-1,257
-12% -$101K 0.25% 115
2023
Q1 		$756K Sell
10,193
-1,351
-12% -$104K 0.27% 112
2022
Q4 		$957K Sell
11,544
-576
-5% -$45.7K 0.36% 81
2022
Q3 		$861K Sell
12,120
-1,400
-10% -$121K 0.38% 80
2022
Q2 		$1.17M Sell
13,520
-600
-4% -$56.2K 0.48% 53
2022
Q1 		$1.53M Buy
+14,120
New +$1.46M 0.54% 38

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Legacy Wealth Asset Management's TECH Position: Q3 2024 in Review

Legacy Wealth Asset Management sold out of Bio-Techne (TECH) in Q3 2024, closing a stake of 2,959 shares — an estimated $212K sold.

Legacy Wealth Asset Management first reported a position in TECH in Q1 2022 and held it in 10 quarters. The position peaked at $1.53M in Q1 2022. 562 funds tracked by Wall St. Rank hold TECH as of Q3 2024.

  • Legacy Wealth Asset Management reported no remaining Bio-Techne position as of Q3 2024 after selling out during the quarter.
  • Legacy Wealth Asset Management sold 2,959 Bio-Techne shares in Q3 2024, an estimated $212K.
  • Legacy Wealth Asset Management first reported a position in Bio-Techne in Q1 2022 and held it in 10 quarters.
  • Legacy Wealth Asset Management's Bio-Techne position peaked at $1.53M in Q1 2022.
  • 562 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2024.

Based on Legacy Wealth Asset Management's 13F filing for Q3 2024, filed 23 Oct 2024.